# Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)

> **NCT04475328** · PHASE3 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 120 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** AngongNiuhuang pill
- **DRUG:** Placebo of AngongNiuhuang pill
- **OTHER:** Standard treatment

## Key facts

- **NCT ID:** NCT04475328
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-07-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04475328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04475328, "Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04475328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*